Newer medicines clawback rate

STO-REC-STATPHN2SMT2 National
22.9%

United Kingdom · 2025

Newer medicines clawback rate in United Kingdom stood at 22.9% in 2025 (ABPI).

Original source
Publisher
ABPI
Authority tier
T2 National
Locator
UK competitive weaknesses
Retrieved
17 Sep 2026
Status
Verified

What the source says

The trend is now downwards, however: the newer medicines rate has fallen to 14.5 per cent in 2026 from a 2025 peak of 22.9 per cent, and agreeing a stable, internationally competitive scheme model from 2029 is the next milestone.

Verbatim extraction verified: The figure 22.9% is directly attested in the quoted passage (UK competitive weaknesses).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
Association of the British Pharmaceutical Industry. (2025). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_PHN2SMK3W3WFKN506YA8B0D87N
MLA
Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2025, https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_PHN2SMK3W3WFKN506YA8B0D87N.
Chicago
Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2025. https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_PHN2SMK3W3WFKN506YA8B0D87N.
BibTeX
@misc{abpi2025newerb0d87n, author = {{Association of the British Pharmaceutical Industry}}, title = {Green shoots for UK pharma investment, but delivery will decide whether they take root}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_PHN2SMK3W3WFKN506YA8B0D87N}, note = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STATPHN2SM T2 National

Primary Source

Publisher
Association of the British Pharmaceutical Industry · homepage ↗
Authority tier
Tier 2 · National Official
Report
Green shoots for UK pharma investment, but delivery will decide whether they take root
Type
Press release
Published
Locator
UK competitive weaknesses
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_PHN2SMK3W3WFKN506YA8B0D87N